Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland. more
Time Frame | RHHBY | Sector | S&P500 |
---|---|---|---|
1-Week Return | -1.12% | 1.54% | 1.33% |
1-Month Return | -9.57% | -4.69% | 1.77% |
3-Month Return | -14.46% | -6.95% | 6.75% |
6-Month Return | 11.9% | -1.69% | 12.03% |
1-Year Return | 6.27% | 10.43% | 30.49% |
3-Year Return | -27.59% | 8.81% | 26.92% |
5-Year Return | -6.91% | 46.58% | 91.02% |
10-Year Return | -5.11% | 109.74% | 187.09% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 61.47B | 58.32B | 62.80B | 63.28B | 60.44B | [{"date":"2019-12-31","value":97.13,"profit":true},{"date":"2020-12-31","value":92.17,"profit":true},{"date":"2021-12-31","value":99.24,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":95.51,"profit":true}] |
Cost of Revenue | 18.35B | 16.18B | 19.65B | 18.51B | 16.36B | [{"date":"2019-12-31","value":93.4,"profit":true},{"date":"2020-12-31","value":82.34,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.22,"profit":true},{"date":"2023-12-31","value":83.25,"profit":true}] |
Gross Profit | 43.12B | 42.15B | 43.15B | 44.77B | 44.08B | [{"date":"2019-12-31","value":96.3,"profit":true},{"date":"2020-12-31","value":94.14,"profit":true},{"date":"2021-12-31","value":96.39,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.47,"profit":true}] |
Gross Margin | 70.14% | 72.26% | 68.72% | 70.75% | 72.94% | [{"date":"2019-12-31","value":96.17,"profit":true},{"date":"2020-12-31","value":99.08,"profit":true},{"date":"2021-12-31","value":94.21,"profit":true},{"date":"2022-12-31","value":97,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 43.92B | 39.78B | 44.65B | 45.80B | 45.05B | [{"date":"2019-12-31","value":95.88,"profit":true},{"date":"2020-12-31","value":86.85,"profit":true},{"date":"2021-12-31","value":97.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.34,"profit":true}] |
Operating Income | 17.55B | 18.54B | 18.16B | 17.48B | 15.39B | [{"date":"2019-12-31","value":94.63,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":97.91,"profit":true},{"date":"2022-12-31","value":94.25,"profit":true},{"date":"2023-12-31","value":83.02,"profit":true}] |
Total Non-Operating Income/Expense | (6.21B) | - | - | - | - | [{"date":"2019-12-31","value":-620937423161,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Pre-Tax Income | 16.61B | 17.96B | 17.40B | 16.33B | 14.08B | [{"date":"2019-12-31","value":92.48,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":96.84,"profit":true},{"date":"2022-12-31","value":90.88,"profit":true},{"date":"2023-12-31","value":78.37,"profit":true}] |
Income Taxes | 2.51B | 2.90B | 2.46B | 2.80B | - | [{"date":"2019-12-31","value":86.5,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":85.02,"profit":true},{"date":"2022-12-31","value":96.51,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | 14.11B | 15.07B | 14.94B | 13.53B | - | [{"date":"2019-12-31","value":93.63,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.12,"profit":true},{"date":"2022-12-31","value":89.8,"profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | 14.11B | 15.07B | 14.94B | 13.53B | 12.36B | [{"date":"2019-12-31","value":93.63,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.12,"profit":true},{"date":"2022-12-31","value":89.8,"profit":true},{"date":"2023-12-31","value":82.01,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 13.50B | 14.29B | 13.93B | 12.42B | 11.50B | [{"date":"2019-12-31","value":94.42,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":97.45,"profit":true},{"date":"2022-12-31","value":86.89,"profit":true},{"date":"2023-12-31","value":80.43,"profit":true}] |
EPS (Diluted) | 29.59 | 11.65 | 7.55 | 1.46 | 6.15 | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":39.36,"profit":true},{"date":"2021-12-31","value":25.52,"profit":true},{"date":"2022-12-31","value":4.93,"profit":true},{"date":"2023-12-31","value":20.79,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
RHHBY | |
---|---|
Current Ratio | 1.35 |
Quick Ratio | 1.04 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
RHHBY | |
---|---|
ROA (LTM) | 12.49% |
ROE (LTM) | 36.36% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
RHHBY | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.63 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.32 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
RHHBY | |
---|---|
Trailing PE | 19.05 |
Forward PE | 11.99 |
P/S (TTM) | 3.80 |
P/B | 6.92 |
EV/R | 3.79 |
EV/Ebitda | 12.98 |
PEG | 1.06 |
Roche Holding Ltd ADR (RHHBY) share price today is $35.44
Yes, Indians can buy shares of Roche Holding Ltd ADR (RHHBY) on Vested. To buy Roche Holding Ltd ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RHHBY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Roche Holding Ltd ADR (RHHBY) via the Vested app. You can start investing in Roche Holding Ltd ADR (RHHBY) with a minimum investment of $1.
You can invest in shares of Roche Holding Ltd ADR (RHHBY) via Vested in three simple steps:
The 52-week high price of Roche Holding Ltd ADR (RHHBY) is $42.43. The 52-week low price of Roche Holding Ltd ADR (RHHBY) is $29.2.
The price-to-earnings (P/E) ratio of Roche Holding Ltd ADR (RHHBY) is 18.8717
The price-to-book (P/B) ratio of Roche Holding Ltd ADR (RHHBY) is 6.92
The dividend yield of Roche Holding Ltd ADR (RHHBY) is 3.82%
The market capitalization of Roche Holding Ltd ADR (RHHBY) is $228.17B
The stock symbol (or ticker) of Roche Holding Ltd ADR is RHHBY